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Abstract 
	  
	  
Background: One population prone to aspiration pneumonia and impaired cough is 
the postoperative patient. Postoperative pneumonia is the third most common complication 
among surgical patients after urinary tract and wound infections (Wren, Martin, Yoon, & 
Bech, 2010). A patient who has their surgical course complicated by aspiration pneumonia 
has increased morbidity, increased length of hospital stay and places greater demands on the 
health system. Mortality rates are cited as high as 70% (Wren, et al., 2010). Despite the 
prevalence of postoperative pneumonia and the high morbidity and mortality rates, little is 
known about the effect of anaesthesia on swallowing and airway protection.  This study 
investigated the effect of clinical doses of fentanyl on suppressed cough reflex in healthy 
participants. 
	  
Materials and Methods: After receiving ethical approval, 14 young, healthy 
participants gave informed written consent and completed the study protocol. Each 
participant received a total of 2 mcg/kg of fentanyl in four doses administered at five-minute 
intervals. Fentanyl effect site concentrations (ESC) were estimated using a standard 
pharmacokinetic model. During the administration period, suppressed cough response testing 
(SCR) with nebulised citric acid was performed after each fentanyl dose. Citric acid was 
presented in increments of 0.2M from each participant’s baseline cough response until a 
present-strong response was achieved. During the post-administration period, SCR was 
compared with reducing effect site concentrations to determine the time course for resolution 
of cough suppression. 
	  
Results: Suppressed cough threshold increased and decreased in parallel with 
modeled fentanyl effect site concentrations. Mean citric acid concentration increased from 
0.5M at baseline to 0.6M after 0.5 mcg/kg of fentanyl, 0.7 M after 1 mcg/kg of fentanyl, 
0.9M after 1.5 mcg/kg of fentanyl and 1.2M after 2 mcg/kg of fentanyl. Predicted effect site 
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concentrations after final doses of fentanyl (2 mcg/kg) were 1.89 ng/mL (1.81-1.96), well 
within the range seen clinically in the postoperative period. After the final dose of fentanyl, 
participants had on average 3.4 increments of change in their cough response (at increments 
of 0.2M). 
	  
Conclusion: SCR testing with citric acid is sensitive enough to mirror changes in 
fentanyl ESC in healthy, young participants. The degree of reflex suppression seen has been 
associated with an 8-fold increase in aspiration risk in the general medical patients with 
dysphagia (Miles, Moore, McFarlane, Lee, Allen, Huckabee, 2013). Further research into 
the application of SCR in the postoperative period may help clinical decisions regarding 
safety to commence oral intake. 
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Chapter 1: Literature Review 
	  
	  
Dysphagia 
	  
	  
Dysphagia is the medical term for difficulty with swallowing (SPAA, 2012). It is 
recognised in the International Classification of Functioning and Health by the World Health 
Organization (www.who/int/classifications/icf/en). International dysphagia prevalence data 
within the acute hospital setting vary dramatically. Australian figures have been reported at 
25% (Cichero, Heaton, & Bassett, 2009) with Spanish figures as high as 55% (Cabre, Serra- 
Prat, Palomera, Almirall, Pallares & Clave, 2010). One American study reported rates of less 
than 1% of hospital admissions related to dysphagia (Altman, Yu, & Schaefer, 2010), 
although they recognise this is likely grossly underreported. Caution should be used in 
directly comparing international rates of dysphagia, given the varying methods used by the 
investigators. For example, in comparing the studies of Cichero et al. (2009) and Cabre at al. 
(2010),  the nature of the samples are very different: 442 Australian patients of unspecified 
age from general medical wards with various reasons for admission, versus 134 Spanish 
patients aged over 70 (mean age 84.51) in an acute geriatric unit who were admitted with 
pneumonia, respectively. It may be these methodological and sampling differences explain 
the discrepancy between the results, rather than country of data collection alone. 
	  
The consequences of dysphagia in the hospitalised patient can be vast. There are 
social and psychological effects as well as risk of nutritional compromise (Ekberg, Hamdy, 
Woisard, Wuttge‚ÄìHannig, & Ortega, 2002). Dysphagia increases length of stay and is a 
poor prognostic indicator (Altman, Yu & Schafer, 2010). In an analysis of the 2005-2006 
American National Hospital Discharge Survey data, Altman et al., (2010) found the median 
length of stay was 4.04 days for patients with dysphagia, versus 2.40 days for those without. 
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Aspiration. 
	  
A primary complication of dysphagia which must be managed in the acute setting is 
aspiration (Wilkins, Gillies, Thomas, & Wagner, 2007). Aspiration, especially if it goes 
undiagnosed, is often the determining factor which increases patient mortality (Altman, et al., 
2010). Aspiration occurs when material enters the larynx and passes below the level of the 
vocal folds. It may be signaled with a cough response (overt aspiration) or may occur in the 
absence of a cough response (silent aspiration). Silent aspiration poses a number of 
difficulties in patient management, primarily because it is poorly detected at bedside 
(Ramsey, Smithard, & Kalra, 2005). 
	  
Historically, the terms ‘aspiration’, ‘aspiration pneumonia’ and ‘aspiration 
pneumonitis’ have been poorly defined in the literature (Finucane & Bynum, 1996). 
Aspiration of colonised oropharyngeal material results in aspiration pneumonia; defined as an 
acute pulmonary inflammation response to bacteria. Aspiration of sterile gastric contents 
results in aspiration pneumonitis; an acute lung injury similar to that of a burn in response to 
acidic gastric material (Marik, 2001). The scientific distinction between these two processes 
can be made based on bacteria type, acidity of material etc. For example: a pH lower than 2.5 
and a volume of at least 20mL are required for the development of aspiration pneumonitis 
(Marik, 2001). However in clinical terms, aspiration (regardless of type of material) occurs 
due to a breakdown in airway protection reflexes at the level of the vocal folds. 
	  
One of the most widely cited articles pertaining to aspiration in the medical speech 
pathology literature is that of Langmore, Turpenning, Schork, Chen, Murray & Lopatin et al., 
(1998). In her landmark study, Langmore followed 189 patients over four years to identify 
the most important risk factors for developing aspiration pneumonia. She offered a three- 
period process to explain the multifactorial development (see figure 1). Firstly, bacteria are 
colonised in the oropharynx, secondly, the bacteria are conveyed into the lungs through 
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aspiration and lastly, impaired pulmonary clearance is ineffective at clearing the aspirated 
material. 
	  
	  
Colonisation	  (altered	  oropharyngeal	  Tlora)	  Dependance	  for	  oral	  cares,	  number	  of	  decayed	  teeth,	  multiple	  medications,	  tube	  feeding	  
	  
	  
	  
	  
	  
Aspiration	  into	  lungs	  Fluid,	  food,	  GER,	  saliva	  Dependence	  for	  feeding	  
	  
	  
	  
Host	  resistance	  Pulmonary	  clearance:	  current	  smoker	  	  Systemic	  immunological	  response:	  multiple	  comorbidites	  
	  
	  
	  
	  
	  
	  
Pneumonia	  
	  
	  
	  
	  
	  
Figure 1. Three-phase process for developing aspiration pneumonia modified from 
Langmore et al., (1998) p.77. 
	  
	  
	  
	  
Healthy individuals aspirate small amounts of their own saliva (Langmore, et al., 
1998), and approximately 50% of healthy people microaspirate secretions during sleep 
(Gleeson, Eggli, & Maxwell, 1997). However, not everyone who aspirates develops 
pneumonia. The above model helps explain why. All three conditions: colonisation, 
aspiration and impaired resistance must be met. While a small amount of aspiration in 
healthy, mobile individuals is normal, aspiration can be fatal for patients with altered 
oropharyngeal flora due to reliance on others for oral cares or tube feeding, those with 
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dysphagia putting them at increased risk of aspiration, or those with compromised 
resistance because of decreased mobility and multiple medications. 
	  
There are limitations of the Langmore et al. (1998) study. Subjects were all male 
veterans aged 60+ years and 112 of the 160 participants had multiple co-morbidities. Also, all 
patients received treatment.  However, it was prospective in nature, included a follow up 
period of four years and had a large number of participants and a control group. The 
definition and distinction of aspiration according to three medical criteria was clearly 
documented and reached by consensus of an experienced panel. Their procedures were 
detailed and each participant received a number of radiographic/ nuclear medicine 
assessments of pharyngeal and oesophageal swallowing function. The overall results of 
Langmore’s study included a larger number of variables and categories of risk than had 
previously been investigated.  Despite being published fifteen years ago, it is still regarded as 
one of the most important papers on this topic. Langmore’s three phase process verified 
clinical knowledge - in order for bacteria to enter the lungs, it must be aspirated and bypass 
the typical mechanisms of airway protection. 
	  
Airway Protection 
	  
	  
Aspiration occurs when there is a breakdown of airway protection mechanisms. 
Airway protection reflexes are: swallowing aponea, cough, expiratory effort and laryngeal 
closure (Widdicombe, 1998). The primary mechanism for airway clearance in humans is the 
cough. Cough is designed to protect the airways from foreign matter once airway closure has 
been ineffective (Pantaleo, Bongianni, & Mutolo, 2002; Dua, Surapaneni, Kuribayashi, 
Hafeezullah, & Shaker, 2011; Lee & Birring, 2012) and is a critical mechanism in airway 
defense (Fontana & Lavorini, 2006; Addington, Stephens, Phelipa, Widdicombe, & Ockey, 
2008). The definition of cough currently accepted by the European Respiratory Society 
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(ERS) was initially published by Korpas & Tomori (1979). They classify cough as a three 
phase motor act characterised by an inspiratory effort (inspiratory phase), followed by a 
forced expiratory effort against a closed glottis (compressive phase) with subsequent opening 
of the glottis and rapid expiratory airflow (explusive phase). 
	  
Airway protection is so essential to human survival that the normally developing 
human fetus can swallow in the 12th week of gestation, prior to development of cortical and 
subcortical structures (Jean, 2001). With maturation, different features of airway protection 
emerge. When water is presented into the pharynx of premature infants they respond with 
multiple swallows, aponea and stridor. Full term infants have the same type of responses but 
of decreased duration. Mature infants respond with a brief aponea and then multiple swallows 
(Thach, 2007). As children mature, aponea and swallowing become less common and the 
cough reflex becomes the primary feature of laryngeal protection in man (Thach, 2007). 
	  
Cough neurophysiology. 
	  
It is generally accepted that the cough reflex is triggered by an irritant stimulating 
vagally innervated sensory receptors within the respiratory tract (Dicpinigaitis, 2003). The 
entire respiratory tract is densely packed with sensory nerve endings. The larynx, the trachea 
and major bronchi are the areas with greatest density of receptors (Fujimura, 1995). The 
literature discusses a number of receptor types, categorised according to origin, location, 
neurochemistry and responsiveness: chemoreceptors, C fibres, nocioceptors, 
mechanoreceptors (including rapidly and slowly adapting stretch receptors), sodium ATPase 
receptors and general ‘cough receptors’ (Mazzone, 2005).The larynx has two types of cough 
receptors: myelinated irregularly firing receptors (Poliacek, Halasova, Jakus, Murin, Barani & 
Stransky et al., (2007) and nonmyelinated C fibre endings (Fujimura, 1995).  These are both 
innervated by the superior laryngeal nerve of vagus (Widdicombe, 1998). The 
tracheobronchial tree also has two types of cough receptors: myelinated rapidly adapting 
receptors (RARs) also 
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called mechanoreceptors, and nonmyelinated bronchial C fibre endings. These are both 
innervated by the pulmonary branch of the vagus (Widdicombe, 1998). These sensory 
receptors relay afferent information through action potentials to the nucleus tractus solitarus, 
where it synapses in the putative ‘cough centre’ in the dorsal medulla of the brainstem 
(O'Connell, 2002). This initiates coordinated motor output: the cough (Nasra & Belvisi, 
2009). 
	  
Cough reflex versus expiratory reflex. 
	  
The general term ‘cough’ can further be defined into different processes which have 
the same observable outcome: the cough reflex and the expiratory reflex. The classic cough 
reflex (CR) has three phases: an inspiratory phase, a compressive phase and an expulsive 
phase (Korpas & Tomori, 1979) as described above. The purpose of the inspiratory phase is 
to increase the force of the explusive phase to support clearance of the tracheobronchial tree 
and lungs. The CR is triggered by receptors within the tracheobronical tree (Fontana & 
Lavorini, 2006). 
	  
The expiratory reflex (ER) also known as the laryngeal expiratory reflex (LER) 
(Fontana & Lavorini, 2006; Widdicombe & Fontana, 2006) has only two phases: a strong 
expiratory phase (against a closed glottis) and an open expiratory phase (as the glottis opens) 
to eject material from the larynx (Tatar, Hanacek, & Widdicombe, 2008). Notably, it does not 
begin with an inspiratory phase; this could permit entry of material into the lungs. The ER is 
triggered at the level of the true vocal folds or upper trachea (Fontana & Lavorini, 2006). 
	  
The CR and the ER have distinctive afferent pathways, CNS circuits, physiological 
presentations and effects to medication (Fontana, 2008). The CR tends to be associated with 
an ‘urge to cough’ while the ER does not (Davenport, Vovk, Duke, Bolser, & Robertson, 
2009). The CR is initiated in the cortex, is triggered by mechanical or chemical stimuli and 
can be cortically modulated and suppressed. The ER is initiated by the brainstem and can not 
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be cortically modulated or suppressed (Miles, Zeng, McLauchlan, & Huckabee, 2013). 
Clinically, it is likely a combination of the CR and the ER that protect the airway in a cough 
epoch (Fontana, 2008; Miles, Zeng, et al., 2013). However, an understanding of the 
differences and commonalities across the two reflexes is an essential part of research design 
in this field. 
	  
Cortical influence on cough 
	  
The cough reflex is more susceptible to cortical modulation and suppression than the 
ER. A further distinction is required between types of cough reflex. Humans are capable of 
both volitional and reflexive cough, the difference being the involvement of the cortex, which 
implies different and distinct pathways (Lee, Cotterill-Jones., & Eccles, 2002). Voluntary 
cough can not be studied in animals (Lasserson et al., 2006) and some researchers have 
questioned whether the reflexive cough elicited in anaesthetised animals can be applied 
directly to man (Nasra & Belvisi, 2009; Lasserson, et al., 2006). The supramedullary 
activation of cough under these conditions is even more doubtful (Widdicombe, Eccles, & 
Fontana, 2006). Volitional cough in humans is often associated with urge to cough, which 
implies cortical involvement. Despite not understanding the exact mechanisms, we know that 
cough can be affected by cortical input. Figure 2 represents volitional and reflexive cough 
pathways. 
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Figure 2. Representation of volitional and reflexive cough pathways (Lee, et al., 2002, p319). 
	  
	  
	  
	  
Lasserson et al., (2006) compared cough flow rates and EMG measurements of 
abdominal muscles in volitional versus reflexive cough elicited with tartaric acid. They found 
the maximum cough flow rate was higher in volitional compared to reflexive cough, and that 
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volitional cough initially activated expiratory muscles and recruited shoulder and thoracic 
accessory muscles as cough strength increased, while in reflexive cough EMG onset was 
simultaneous for both expiratory and accessory muscles. They reported the variances in 
volitional versus reflexive cough were explained by functional organizational differences of 
muscle activation. Bolser & Davenport (2002) report that in voluntary cough, subjects can 
determine the perceived need for input of additional accessory muscles. 
	  
To highlight the influencing role of the cortex in cough, there is a body of research 
that shows higher suppressed cough thresholds compared to natural cough thresholds. In 
suppressed cough testing, participants are instructed to try not to cough. The first to 
investigate this phenomenon were Hutchings, Morris, Eccles & Jawad (1993). They studied 
24 healthy young volunteers. In the natural condition, 23/24 coughed at their highest dose of 
capsaicin, compared to only 3/24 at the same dose in suppressed cough condition.  Similar 
results have been found since. Significantly higher suppressed cough thresholds than natural 
cough thresholds to citric acid were observed in both healthy participants and those with 
Parkinson’s disease, regardless of age or disease severity (Leow, Huckabee, & Anderson, 
2006).  Monroe (2010) studied 80 healthy participants (elders and youngers matched for 
gender). She found a statistically significant difference between natural and suppressed cough 
responses (mean= 0.86 and 1.39 respectively) in the younger group (p=0.001). Hegland, 
Bolser & Davenport (2012) investigated 20 healthy participants using very high 
concentrations of capsaicin. In the suppressed condition, they observed a number of airway 
protective behaviors other than cough (swallowing, throat clearing, breath holding). They 
concluded that healthy participants can modify their cough response by using these 
behaviours, even at high doses of capsaicin where suppression is not possible. 
	  
Further supporting the role of the cortex in cough modulation is the suppression of the 
reflexive cough during sleep (Lee & Birring, 2010; Hsu, 1994; Nishino, Tagaito, & Isono, 
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1996; Widdicombe & Singh, 2006). Wang, Nakagaawa, Sekizawa, Kamanaka, & Sasaki 
(1998) assessed 11 patients and 12 controls across a 24 hour period. They demonstrated 
significantly higher cough thresholds to citric acid at night compared to the day in both the 
patient group (with a history of aspiration pneumonia) and the control group. Interestingly, 
all ‘night’ coughs were associated with arousal. 
	  
Cough is also known to be suppressed during anaesthesia (Kluger & Short, 1999; 
AstraZeneca., 2012; LeGrand, Khawam, Walsh, & Rivera, 2003). Tagaito, Isono, & Niskino 
(1998) investigated the effects of combined propofol anesthesia and fentanyl on airway 
reflexes of 22 healthy female patients. They presented distilled water to the laryngeal mucosa 
and recorded responses as CR, ER, aponea or spasmodic panting. They clearly defined each 
term in their study and had robust verification procedures in place. They found of all the 
airway reflexes, the CR was the most susceptible to the opioid fentanyl. Several studies in 
man have shown that inhaled opiates do not suppress the CR (O'Connell, Thomas, Fuller, 
Pride, & Karlsson, 1994). However, inhaled opiates are not used clinically, limiting the 
application of this research to clinical practice. Of more interest is the finding that systemic 
opiates (intravenous administration) do suppress the CR (Fuller, Karlsson, Choudry, & Pride, 
1988; O'Connell, 2002). A limitation of the Fuller et al., (1998)  study was that participants 
who underwent the inhaled and oral administration of opioid were not the same participants 
who received the IV administration of opioid, making intra-subject assessment across 
conditions impossible. 
	  
O’Connell (2002) reported a significant effect of IV morphine on capsaicin cough 
response. This was significantly attenuated by pre-treatment with the serotonin inhibitor 
pizotifen, compared with saline. However, the authors did not use an effect site concentration 
model to more precisely determine the action of morphine at the time of cough testing. 
Patients received 0.15mg/kg of morphine administered over 15 minutes dependent on weight, 
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and the pre-treatment with piztofen was a set dose of 1.5mg, given at 12 hours and 2 hours 
pre-IV infusion of the opioid. 
	  
	  
	  
	  
Cough reflex testing. 
	  
	  
Given the importance of cough as the primary airway defense mechanism and the 
implications of impaired cough (morbidity and mortality) for the hospitalised patient, cough 
reflex testing (CRT) is now used in clinical speech pathology practice to assess the integrity 
of the laryngeal cough reflex (Fujimura, 1995). CRT is also known as the inhalation cough 
challenge (Dicpinigaitis, 2007; Morice, Kastelik, & Thompson, 2001) or reflex cough test 
(RCT) (Addington, Stephens, & Gilliland, 1999). It is distinct from bronchial provocation 
tests. Cough reflex testing involves the delivery of a tussive agent whereas bronchial 
provocation testing involve the delivery of constricting substances (Morice, et al., 2001). 
	  
Cough reflex testing began in the 1950’s as a response to the expanding production of 
synthetic antitussive drugs and the need to test and compare efficacy (Bickerman, Barach, & 
Drimmer, 1954). Prior to this, antitussive effectiveness had been assessed using ammonia 
vapor, cigarette smoke or sulphur dioxide (Gravenstein, Devloo, & Beecher, 1954). These 
tests were unpleasant and often conducted on institutionalized patients (Cass & Frederik, 
1951). There are a number of potential methodological flaws with trials using this patient 
group. They were presumably more likely to be on antipsychotic or sedative medications 
which could affect central nervous system function, they commonly had co-morbidities 
including respiratory disease and or chronic cough (Cass, 1951) and they tended to have a 
rather variable presentation (Bickerman, et al., 1954). All these factors make it difficult to 
apply any findings of an antitussive effect to the general population. 
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Bickerman et al., (1954)  aimed to achieve three design features in their cough 
	  
reflex test: 1) consistent intra-subject response to a set dose of citric acid; 2) reliability of that 
response across time and 3) an overall test which was non-toxic and simple to administer, to 
allow for large scale normative studies to be undertaken. Despite these design features being 
proposed over fifty years ago, unfortunately the literature still does not have a standard 
method of administration for the cough reflex test. The delivery of tussive agents in cough 
challenge requires a nebuliser to convert the liquid agent into aerosol particles (Morice, et al., 
2001). The diameter of the particles affects where they will be deposited in the respiratory 
tract. Several nebulised chemical stimuli can induce cough in man and animals (Nasra & 
Belvisi, 2009). Bickerman et al., (1954) tested 33 different aerosol substances  in 153 
patients over a two year period. They overcame the flaws of prior studies that had 
investigated institutionalised patients only by testing healthy volunteers, who more likely 
represented the general population. They did, towards the end of recruitment, include 17 
participants who had well-controlled asthma. The results indicated that citric acid, tartaric 
acid and benzoic acid yielded more consistent responses than the other 30 agents. These 
results were supported by recent literature indicating capsaicin and citric acid are the most 
reproducible agents (Morice, Fontana, et al., 2007). 
	  
The most widely used agents in cough testing today are citric acid, tartaric acid and 
capsaicin (Morice, et al., 2001). Citric acid and tartaric acid are organic acids (Bickerman, et 
al., 1954).  Capsaicin is the active ingredient in red pepper (Fujimura, 1995). One benefit of 
citric acid is that if the chemical stimuli causes a mechanical distortion of the nerve terminal 
it can activate both chemoreceptors and low threshold mechanoreceptors (Mazzone, 2005). 
High doses of opiates inhibit capsaicin induced cough, while beta agonsist medications such 
as sodium cromoglycate and nedocromil sodium do not affect capsaicin (Fuller, 1991). 
THE	  EFFECT	  OF	  FENTANYL	  ON	  COUGH	  RESPONSE	   23	  	  
	  
	  
	  
Perhaps the most discernible difference in cough testing between different research 
groups is the administration method: single dose or dose response method (see figure 3). 
Single dose inhalation challenge involves presentation of one set concentration of the tussive 
agent (Morice et al., 2007). This is a rapid method of assessment which has been used largely 
in screening studies and when investigating duration of anti-tussive agents such as menthol 
and dextromethorphan on cough reflex (Morice, Marshall, Higgins, & Grattan, 1994). 
	  
 
	  
	  
	  
Figure 3. Different methodology used in cough testing (Morice, et al., 2001, p367). 
	  
	  
	  
	  
Dose response challenge involves presentation of increasing concentrations of the 
tussive agent, with placebo presentations of saline. Dose response is also known as threshold 
testing. This method is further categorized into single breath and fixed time inhalation 
challenges. Single breath has subjects perform maximum exhalation and inhale via 
mouthpiece for 1 second. Fixed time inhalation usually ranges from 15- 60 seconds. 
However, the ERS guidelines state the sixty-second inhalation period has been conducted 
with a small number of subjects, has delivery complications and should no longer be used 
(Morice, Fontana, et al., 2007). 
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The dose of tussive agent required to elicit two successive coughs and/ or five 
successive coughs is reported, respectively known as C2 and C5 response. There is a debate 
as to which value has the most clinical importance, however researchers such as O’Connell, 
Thomas, Studham, Prode & Fuller (1996) report C2 is the more reproducible measure. 
	  
Tachyphylaxis is the diminished system response to latter increments of presentation 
of the tussive agent  (medical-dictionary.thefreedictionary.com). It can occur in repeat cough 
challenges (Morice, et al., 2007). Compared with dose response testing, single dose method 
has a lower likelihood of inducing tachyphylaxis due to the smaller number of inhalations 
required. Tachyphylaxis is therefore a risk of the dose response approach. To prevent this, a 
period of between 30-60 seconds rest between administrations is recommended (Morice, 
1996). 
	  
Due to the distinction between natural and suppressed cough conditions; 
consideration should be given to the instructions patients receive in the administration of 
cough testing. Typically, under the ‘natural’ condition, the instructions will be “cough if you 
need to” (or similar) which may alert the cognitively intact patient to the likelihood of 
coughing. In the suppressed condition, patients are typically instructed to “try not to cough” 
and this may in fact represent a better assessment of reflexive cough. 
	  
There is currently no gold standard for methodology of cough reflex testing 
administration, and due to difference in protocols and it is not possible to compare results 
between research groups (Barber, 2005; Morice, et al., 2001). However, there is a growing 
body of evidence that cough reflex testing gives useful clinical information. Nakajoh, 
Nakagawa, Sekizawa, Matsui, & Sasaki (2000) showed a significant inverse relationship 
between strength of cough reflex and incidence of pneumonia in the stroke population. 
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Clinical application of cough testing in swallowing assessment. 
	  
In clinical dysphagia management, it is often difficult to determine whether a patient’s 
airway protection mechanisms are intact or not, affecting decisions such as when eating and 
drinking can safely be commenced (Addington, Stephens & Gilliand, 1999). We have long 
known that traditional bedside evaluations are insensitive to the phenomenon of silent 
aspiration.  An important paper by Splaingard, Hutchins, Sulton, & Chaudhuri (1988) 
reported that up to 70% of silent aspirators went undiagnosed on bedside swallowing exam. 
In applying the findings of that paper to clinical practice, it is likely that these patients were 
started on oral diets and put at risk of aspiration pneumonia because it was not possible to 
differentiate silent aspirators from non-aspirators. 
	  
Addington et al., (1999) evaluated the use of cough testing for identifying acute 
stroke patients at risk of silent aspiration. Administration was via mouthpiece using a tartaric 
acid solution. Response was described as normal or abnormal. Of the 400 patients who had a 
normal response, only 5 went on to develop aspiration pneumonia (1.25%) compared to the 
control group of 204 patients, who received traditional assessment, in which 27 went on to 
develop pneumonia (13.25%).  These results supported the clinical application of cough 
testing in identifying stroke patients who were at risk of silent aspiration. One limitation of 
the Addington et al. (1999) study was population bias. The treatment group was from one 
hospital, the control group from a ‘sister’ hospital. The treatment group was comprised only 
of patients who were able to follow the commands required to complete CRT via mouthpiece 
administration. Using a mouthpiece and requiring participants to fully exhale and then deeply 
inhale requires a degree of receptive language skill and motor control not always seen in the 
acute stroke population due to the high incidence of aphasia, cranial nerve impairment and 
apraxia. The control group included those with severe deficits who would have been  
excluded from the treatment group. This may have skewed the results. 
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More recently within New Zealand, researchers have implemented a facemask 
administration method which requires participants to breathe passively for 15 seconds using a 
nebuliser with a set output of 8L/minute and citric acid (Leow, et al., 2006; Miles & 
Huckabee, 2012; Miles, Moore, et al., 2013; Miles, Zeng, et al., 2013). Results of their cough 
sensitivity data correlate highly to instrumental investigations such as videofluoroscopy and 
fibreoptic endoscopic evaluation of swallowing. They found that at a dose of 0.8M citric acid, 
patients who had an abnormal cough response were 8 times more likely than those with a 
present response to silently aspirate under videofluoroscopy (odds ratio of 8.0) (Miles, 
Moore, et al., 2013). 
	  
The literature surrounding the application of cough reflex testing in dysphagia 
management is substantial; discussion of all of which is outside the scope of this review. 
Landmark studies with the greatest relevance to this research have been reviewed above. 
	  
Postoperative aspiration 
	  
	  
One population prone to aspiration pneumonia with an etiology of impaired cough is 
the postoperative patient. Potential risk factors for aspiration include oesophageal disease 
(Kluger & Short, 1999), obesity (Kluger & Short, 1999), neurologic impairment (DeLegge, 
2002), advancing age (DeLegge, 2002), gastroesophageal reflux (DeLegge, 2002), tube 
feeding (DeLegge, 2002) and decreased level of consciousness, including anaesthesia 
(DeLegge, 2002; Nishino & Hiraga, 1991). 
	  
Aspiration is a known risk of general anaesthesia, occurring in approximately 1 of 
3000 operations (Marik, 2001). In a national survey, 71% of New Zealand based specialist 
anaesthetists reported between 1 and 10 instances of aspiration during their career (Kluger & 
Willemsen, 1998). However, it is not clear from the article how the anaesthetists made this 
assessment (evidence of overt penetration/aspiration during surgery as opposed to review of 
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chest x-ray post operatively) and no distinction was made between aspiration pneumonia 
and aspiration pneumonitis. It is possible this figure is under reported due to the incidence of 
silent aspiration in the anaesthetised patient. 
	  
Postoperative pneumonia is the third most common complication among surgical 
patients after urinary tract and wound infections (Wren, et al., 2010). A patient who has their 
surgical course complicated by aspiration has increased morbidity, increased length of 
hospital stay and places greater demands on the health system. In the intensive care setting, 
aspiration pneumonia can translate into additional healthcare costs of as much as US$40,000 
per patient (Wren, et al., 2010). The prognosis for patients with postoperative pneumonia is 
poor (Wren, et al., 2010). Once diagnosed, aspiration pneumonia has a mortality rate between 
20% and 70% (Wren, et al., 2010; Warner, Warner, & Weber, 1993). 
	  
Despite the prevalence of postoperative pneumonia and the high morbidity and 
mortality rates, not to mention the associated costs to the system, fairly little is known about 
the direct relationship between anaesthesia and the effects on cough reflex.  Opioids are 
commonly given during anaesthesia to reduce perception of pain. It is possible that their 
action contributes to the clinical presentation of postoperative pneumonia by impairing 
cough: a known side effect. 
	  
Opiates are among the oldest drugs in the world (Brownstein, 1993; Trescot, Datta, 
Lee, & Hansen, 2008). Natural opiates are derived from the opium poppy, while synthetic 
opiates are specifically manufactured with a similar chemical structure. Natural and synthetic 
forms of opiates are collectively called opioids. The opioid system controls pain, reward and 
addiction (Kieffer & Gavriaux-Ruff, 2002). Side effects of opioids include sedation, 
respiratory depression, cough suppression, constipation and euphoria.  The exact nature of 
respiratory depression remains unclear (LeGrand, et al., 2003). The generally accepted theory 
is that the respiratory centres housed in the medulla of the brainstem become less responsive 
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to states of hypoxia and hypercapnia (Saito, Sakura, Kaneko, & Kosaka, 1995). Another 
explanation, offered by LeGrand et al. (2003) is that opioids may influence the 
neurotransmitters of the medulla such as acetylcholine, 5-hydroxytryptamine, and 
noradrenaline. In terms of cough suppression, opiates are the most effective drugs for this 
purpose (Chung & Chang, 2002) and are the most commonly prescribed antitussives in 
chronic cough (Chung, 2007; Morice et al., 2007). 
	  
Prior to the 1800s, the use of opioids in surgery was haphazard. Sponges soaked in 
opium to decrease pain gave a variable rate of delivery/ absorbency and were dangerous 
(Brownstein, 1993). With the invention of the hypodermic syringe in the 1850’s opioids 
began to be used as an adjunct to general anesthesia, both during and after to reduce pain 
perception and reaction to pain (Beilin, Shavit, Hart, Mordashov, Cohn & Notti et al., (1996). 
They continue to be used in this way today. 
	  
The analgesic effects of opioids occur by essentially blocking the transmission of 
pain to the brain.  Opioids exert their action by binding to opioid receptors. There are three 
principle classes of opioid receptors: mu (µ), kappa (⎢) and delta () (Sigma-Aldrich, 1996). 
These opioid receptors are activated by endogenous opioid peptide genes: short sequences of 
amino acids. Each opioid receptor was named after the initial Greek letter of the drug that 
first bound to it.  For example, morphine was first the first drug found to bind to mu 
receptors, depicted with the Greek ‘m’ symbol µ  (Trescot et al., 2008). 
	  
Based on the initial finding of opioid receptors within the central nervous system 
(CNS) it was thought that opioids only acted centrally (Adcock, 1991) and that their effects 
on respiration and cough must also be brought about centrally. However, we now know that 
opioid receptors are present not only in the CNS, but also in the peripheral nervous system 
(PNS) including peripheral sensory and autonomic nerves (Sigma-Aldrich, 1996), the airway 
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and GI tract (Cabbott, 1994). Interestingly, the highest concentration of binding sites lie 
within the alveolar wall, tracheal and bronchial smooth muscle (LeGrand, et al., 2003). 
	  
Fentanyl 
	  
	  
Pharmacology 
	  
Fentanyl citrate is a synthetic opioid analgesic chemically identified as N-(1- 
phenethyl-4—piperidyl) propionanilide citrate. It has a molar weight of 528.61 
(AstraZeneca., 2012). 
	  
Indications for fentanyl include: use as short duration analgesia in anaesthesia 
(premedication, induction and maintenance) and in the immediate postoperative period, or as 
an analgesic supplement to regional or general anaesthesia (MIMS New Ethicals, 2012). 
Contraindications include: intolerance to morphinominetics, asthma, respiratory depression 
susceptibility e.g. coma with possible head injury or brain tumour, history of myasthenia 
gravis, MAOIs within 14 days (MIMS New Ethicals, 2012). 
	  
International guidelines generally recommend morphine or fentanyl as opioid 
medications for acute pain (Ward & Yealy, 2000). Fentanyl has similar action to morphine 
but is faster acting and has a shorter duration. Fentanyl’s onset of action is approximately 3 
minutes, versus morphine which takes approximately 10-15 minutes (Galinski et al., 2005). 
The duration of action of fentanyl is 30 minutes to 2 hours, whereas morphine has a duration 
of 3 to 4 hours (Galinski, et al., 2005). Fentanyl is much stronger than morphine; it is 
approximately 50-100 times as potent when compared mg to mg. For example, a dose of 
100µg of fentanyl (0.1mg or 2.0mL) is equivalent in analgesic effect to 10mg of morphine 
(AstraZeneca., 2012). Fentanyl does not affect cardiac function or histamine release. The 
elimination half life of fentanyl is 114 minutes, whereas that of morphine is 185-220 minutes 
(Ward & Yealy, 2000). 
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Pharmacodynamics 
	  
Fentanyl is known to frequently decrease respiratory rate. The duration and degree of 
this depression is dose dependent. The peak effect of respiratory depression can be expected 
five to fifteen minutes post intravenous administration (AstraZeneca., 2012). The duration of 
respiratory depression may be longer than the analgesic effect. The NZ Fentanyl fact sheet 
describes decreased sensitivity to carbon dioxide (C02) stimulation up to four hours post 12ml 
(600µg) IV dose in healthy volunteers (AstraZeneca., 2012). 
	  
Pharmacokinetics 
	  
The onset and duration of action of any drug is affected by route of administration. 
When fentanyl is administered intravenously, its onset of action is almost immediate. Its 
maximum analgesic and CNS depressant effects last for several minutes. For a 100µg IV 
dose, the predicted duration of analgesia is 30-60 minutes (AstraZeneca., 2012). 
	  
Using mathematical modeling, scientists can estimate concentrations of drug in the 
plasma and effect site. The modeling is based on a mathematical generation known as a 
‘compartment model’. This concept essentially refers to a drug being injected into the 
‘central compartment’ or plasma, then running to the ‘peripheral compartment’ (where first 
and second pass clearances will occur) and finally entering the ‘effect compartment’ or brain. 
Effect site concentration is a calculated apparent concentration of fentanyl at the brain 
receptors and is therefore the best surrogate of drug effect. The plasma concentration is a true 
measure of plasma concentration, however clinically it is more important to know the effect 
site concentration because that is where the drug acts. “The concentration of a drug at the 
effect site, not the plasma concentration, governs the drug effect” (Shafer & Varvel, 1991). 
	  
The pharmacokinetics of fentanyl are described by a three-component model: a distribution 
time of 1.7 minutes, redistribution of 13 minutes and a terminal elimination half life of 219 
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minutes (AstraZeneca., 2012). Fentanyl is routinely prescribed and administered across the 
perioperative period. 
	  
Summary 
	  
	  
For the development of aspiration pneumonia there must be colonisation of 
oropharyngeal secretions, aspiration of this material into the airway (with or without food) 
and impaired patient resistance to clear the aspirated material. In the hospitalised patient, risk 
factors for all three conditions are increased. Typically, airway clearance is provided through 
the cough reflex, however the cough reflex is impacted by opioids and anaesthesia. 
Aspiration is a recognised complication of anaesthesia and postoperative pneumonia has 
mortality rates as high as 70% (Wren, et al., 2010). Hospital acquired pneumonia, including 
perioperative pneumonia, is the leading cause of nosocomial infection resulting in death in 
America (Tablan, Anderson et al., 2003). Despite these alarmingly high figures, very little 
research investigates clinically relevant means of identifying these patients and how to 
decrease their risk of postoperative aspiration. 
	  
One means of assessing the integrity of the vagally mediated cough reflex is through 
cough reflex testing. Significant relationships have been established between clinical 
application of cough reflex testing and reduction in pneumonia rates in the acute hospital 
setting (Miles, Zeng, et al., 2013; Nakajoh, et al., 2000). Studies have administered drugs 
(including opioids) to participants in an attempt to elucidate the effect they have on airway 
protective reflexes such as cough (Fuller, Karlsson, Choudry, & Pride, 1988; O'Connell, 
Thomas, Fuller, Pride, & Karlsson, 1994).  However, none of these have included cough 
testing in a clinically applicable way in the post-surgical population. One major facet that 
appears to be missing from the literature is the time course for resolution of effects of opioids 
on the cough response. Clinically, it is important to know when the effects of cough 
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suppression attributable to anesthesia have worn off. This would aid the decision making 
of multidisciplinary teams in identifying which patients are safe to begin oral intake with 
intact airway protection in the event of aspiration, compared to those patients who continue to 
have impaired airway protection in the postoperative period. 
	  
Hypotheses 
	  
	  
We hypothesised that: 
	  
	  
1. As the intravenous dose of fentanyl was increased in the administration period, cough 
thresholds would increase and cough sensitivity would decrease. That is, a higher 
dose of citric acid would be required to elicit a cough response classed as ‘present’. 
	  
2. As the effect of fentanyl diminished with time in the post administration period there 
would be a time course for resolution of effects, including cough thresholds. That is, 
over time cough sensitivity would increase and cough response would return to 
baseline. 
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Chapter 2: Methodology 
	  
	  
Participants 
	  
	  
Following approval from the Southern Health and Disability Ethics Committee, the 
Canterbury District Health Board and the University of Canterbury Ethics Committee, 
healthy volunteers aged 18-70 were invited to participate in this study.  The exclusion 
criteria were: 
	  
• Allergy to opioids 
	  
	  
• History of asthma 
	  
	  
• History of chemical addiction 
	  
	  
• History of neurological impairment (e.g. stroke, Myasthenia Gravis) 
	  
	  
• Use of nicotine 3 months prior to study 
	  
	  
• Alcohol consumption 8 hours prior to study 
	  
	  
• Use of MAOI antidepressants 14 days prior to study 
	  
	  
• Any medical or nursing professional/ student who may have current or future access 
to fentanyl. 
	  
• Weight over 100kg. 
	  
	  
Further to the exclusion criteria, our initial research protocol included an exit 
criterion, which stated that participants who met the inclusion criteria would be excluded if 
they failed to produce 2 strong consecutive coughs on 2/3 administrations (C2 response) at 
0.8M citric acid nebulised via facemask (i.e. if they could suppress cough at this dose) on 
baseline assessment. The rationale for this was to monitor for return of cough response to 
baseline prior to departure. The choice of 0.8M citric acid as a ‘cut off’ was based on the 
THE	  EFFECT	  OF	  FENTANYL	  ON	  COUGH	  RESPONSE	   34	  	  
	  
	  
	  
work of Manco, Bennett & Huckabee (2011) which found that 83.8% of the population 
have a natural cough response to 0.8M citric acid and that 91.9% of the population will 
generate a suppressed cough response at 0.9M citric acid. 
	  
Following the initial application of the protocol where a number of participants were 
excluded by the exit criterion, the research team removed this criterion and allowed each 
participant to act as their own control for the dose of citric acid required for them to produce 
2 strong consecutive coughs on 2/3 administrations (C2 response).  The range of citric acid 
used was 0.4M, 0.6M, 0.8M, 1.0M, 1.2M, 1.4M, 1.6M. The advantage of this change was 
that all participants who were eligible to participate in the study could be completed 
successfully and it allowed for normalisation of the data to each individual participant. As an 
example: if participant A had a baseline cough response at 0.4M citric acid, he would need 
to produce a C2 cough response at 0.4M prior to departure as a criteria of leaving. That is, 
would have returned to his suppressed cough response baseline. 
	  
A total of 17 healthy participants aged 18-44 gave informed written consent and were 
enrolled in the study. Three of these participants (1M1901, 7F0883, 8M0875) met the exit 
criteria described above prior to the change in protocol and are not included. Therefore, a 
total of 14 participants are included in data analysis (n=14). Characteristics are outlined in 
Table 1. The age range of participants was 22-44 years. The average age was 28.71 years (SD 
of 6.39). Five of the participants were male (35.7%), 7 were female (64.3%). Twelve of the 
participants identified as New Zealand European (85.7%), and two identified as European 
(14.3%). The height range of participants was 163-181cm. Average height was 171.5 cm (SD 
of 5.74). The weight range of participants was 57.7-91kg. Average weight was 57.7kg (SD of 
11.48). Individuals’ height and weight data were collected to determine dosing levels of 
fentanyl and to allow for generation of 
dose-response curves. For exact dosing model, refer to ‘administration period -calculation of 
fentanyl dose’ (pg 37). 
THE	  EFFECT	  OF	  FENTANYL	  ON	  COUGH	  RESPONSE	   35	  	  
	  
	  
	  
Table 1 Participant Characteristics 
	  
	  
ID	   	  Age	   Sex	   Ethnicity	   Height	  
(yrs)	   	   	   (cm)	   Weight	  (kg)	  2M0582	   30	   M	   NZE	   172	   71.3	  
	   3F0790	   	   22	   	   F	   	   NZE	   	   168	   	   63.6	  
	   4F0984	   	   29	   	   F	   	   NZE	   	   178	   	   83.6	  
	   5M0778	   	   34	   	   M	   	   NZE	   	   170	   	   91.0	  
	   6M0889	   	   23	   	   M	   	   NZE	   	   178	   	   87.3	  
	   9F0281	   	   32	   	   F	   	   NZE	   	   170	   	   76.9	  
	   10F0579	   	   34	   	   F	   	   Eu	   	   170	   	   62.2	  
	   11M1078	   	   34	   	   M	   	   NZE	   	   175	   	   78.6	  
	   12F0168	   	   44	   	   F	   	   NZE	   	   173	   	   62.8	  
	   14M0589	   	   24	   	   M	   	   NZE	   	   181	   	   82.8	  
	   15F1089	   	   23	   	   F	   	   NZE	   	   163	   	   58.8	  
	   16F125	  89	   	   23	   	   F	   	   NZE	   	   164	   	   57.7	  
	   17F0390	   	   23	   	   F	   	   NZE	   	   163	   	   59.6	  
	   18F0785	   	   27	   	   F	   	   Eu	   	   176	   	   76.0	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Procedure 
	  
	  
Healthy participants attended the Gastroenterology Day Unit at Christchurch 
Hospital. This unit is designed to monitor patients post-surgical/ medical intervention. It is 
fully equipped with monitoring equipment, emergency equipment, resuscitation trolley and 
emergency call button to activate the ICU emergency response team. 
	  
For each participant, total participation time was 1.5- 2 hours. This was broken into 3 
periods: 
	  
1. Pre-administration period 
	  
	  
2. Administration period 
	  
	  
3. Post-administration period 
	  
	  
Pre-administration period 
	  
Participants were given a verbal explanation of what their participation involved and 
the written ‘participant information sheet’ (please see appendix A). They then had the 
opportunity to ask questions before signing the consent form (please see appendix B). 
	  
Basic recordings such as height and weight were taken as well as baseline recordings 
of oxygen saturation (Sa02), non-invasive blood pressure (NIBP), heart rate (HR) and 
respiratory rate (RR). These were displayed on the electronic monitors across the study and 
were recorded at 5-minute intervals as per hospital protocol to ensure patient vital stability. 
	  
Participants were directed to a bed space in the gastroenterology day unit. They 
remained comfortably semi-reclined on a bed throughout the pre-administration and 
administration phases. 
	  
Baseline suppressed cough response (BSCR) was measured and response recorded. A 
facemask connected to a DeVelbis Pulmomate nebuliser with a constant unobstructed flow 
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rate of 8L/min was placed over the participants’ mouth and nose. Participants were asked 
	  
to “breathe in and out normally and to suppress the urge to cough”. Solutions of citric acid 
diluted in 0.9% Sodium Chloride were prepared by the Christchurch Hospital Pharmacy at 
concentrations of 0.4M, 0.6M, 0.8M, 1.0M, 1.2M, 1.4M, 1.6M. The dosing began at the 
lowest citric acid concentration of 0.4M. Presentations then increased in increments of 0.2M, 
interspersed randomly with saline until a C2 response was obtained. Each dose was 
administered for a maximum of 15 seconds with a minimum of 30 seconds between each 
dose to prevent tachyphylaxis (Morice, 1996). Each dose was administered up to 3 times to 
ensure consistency of response. The response was categorised as present (2 strong coughs on 
2/3 administrations) or absent (no cough on 2/3 administrations). Present responses were then 
rated as strong or weak.  Each participant served as their own control for the dose of citric 
acid required for them to produce 2 present - strong responses on 2/3 administrations (C2 
response). This baseline dose became the starting dose for each participant on each cough 
test. 
	  
Participants had an intravenous cannula inserted into their arm using subcutaneous 
lignocaine 0.1% under sterile conditions. 
	  
Administration period 
	  
Calculation of fentanyl dose. 
	  
Drugs were signed in and out of controlled drug cupboards by the study doctor and 
counter-signed by the study nurse according to national guidelines. Each participant received 
4 titrated doses of IV fentanyl administered at intervals of 5 minutes. Each of the 4 doses was 
calculated at 0.5 mcg/kg and verified by a second researcher. The dosing model used to 
determine total dose was 0.5mcg fentanyl per kg (x 4). The maximum total dose a participant 
could receive (at a maximum weight of 100kg) was 200mcg fentanyl. Example dosages are 
below: 
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• For a 100kg participant = 0.5mcg x 100 x 4= 200 mcg total dose. 
	  
	  
• For a 70 kg participant =  0.5mcg x 70 x  4 =140 mcg total dose. 
	  
	  
• For a 50 kg participant =  0.5mcg x 50 x 4 = 100 mcg total dose. 
	  
	  
Cough response 
	  
Suppressed cough response (SCR) was tested 3 minutes after each intravenous 
fentanyl administration. Testing began at the baseline citric acid dose for that individual. 
Presentations then increased in increments of 0.2M, interspersed randomly with saline and 
with a minimum of 30 seconds between trials until the C2 response was obtained using the 
method described above. If a participant elicited a present response (strong or weak) at a 
given dose of citric acid no higher doses of citric acid were tested. An absent response 
resulted in administration of higher doses, in increasing increments of 0.2M. 
	  
Post-administration period 
	  
In order to investigate the effects of fentanyl on cough reflex post-administration (as 
the effect site concentration was decreasing) cough response testing was continued.  Each 
participant was tested at 10-minute intervals following administration of the final dose of 
fentanyl and subsequent cough testing (F4CRT) using the method described above. 
	  
Following Post4CRT, or return to baseline cough response, whichever came first 
participants were examined by the study doctor and if deemed medically stable, had their IV 
cannula removed and were disconnected from vital monitoring equipment. Participants were 
then directed to the recovery lounge in the Gastroenterology Day Unit where they were 
monitored. Their safety to leave under the supervision of a responsible adult as per 
Christchurch Public Hospital Protocol was determined by criteria below. 
	  
• Present strong cough response at individual baseline dose of citric acid (i.e. return to 
baseline) 
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• Assessed as meeting criteria by RN expert (e.g. stable vital signs, walk straight 
line) 
	  
• Responsible adult can assume care and drive participant home 
	  
	  
• IV line removed 
	  
	  
• Participant felt well enough to leave 
	  
	  
• Participant had no further questions. 
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Table 2 Study protocol showing timing for participant A 
	  
Time	   Action	   Information	  
Pre-­‐-­‐-­‐administration	  period	  
0800	   Provision	  of	  information	  and	  consent.	   	  
	   Height	  and	  weight	  taken.	  Directed	  to	  bedspace.	   	  
0815	   Baseline	  cough	  response	  (BCR).	   Beginning	  at	  0.4M	  
0820	   IV	  line	  sited	  by	  study	  doctor.	   	  
	   Vital	  sign	  monitor	  attached.	   Sp02,	  HR,	  RR,	  NIBP	  
0825	   Vital	  signs	  recorded.	   	  
Administration	  period	  
0830	   First	  administration	  of	  fentanyl	  (F1)	   	  
	   Record	  all	  4	  vital	  signs	  (RR,	  HR,	  Sa02,	  NIBP)	   	  
0833	   Cough	  response	  post	  F1	  (F1CRT)	   Starting	  from	  baseline	  dose	  
0835	   Second	  administration	  of	  fentanyl	  (F2)	   	  
	   Record	  all	  4	  vital	  signs	  (RR,	  HR,	  Sa02,	  NIBP)	   	  
0838	   Cough	  response	  post	  F2	  (F2CRT)	   Starting	  from	  baseline	  dose	  
0840	   Third	  administration	  of	  fentanyl	  (F3)	   	  
	   Record	  all	  4	  vital	  signs	  (RR,	  HR,	  Sa02,	  NIBP)	   	  
0843	   Cough	  response	  post	  F3	  (F3CRT)	   Starting	  from	  baseline	  dose	  
0845	   Fourth	  administration	  of	  fentanyl	  (F4)	   	  
	   Record	  all	  4	  vital	  signs	  (RR,	  HR,	  Sa02,	  NIBP)	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0848	   Cough	  response	  post	  F4	  (F4CRT)	   Starting	  from	  baseline	  dose	  
Post	  administration	  Period	  
0850	   Record	  all	  4	  vital	  signs	  (RR,	  HR,	  Sa02,	  NIBP)	   	  
0900	   Cough	  response-­‐-­‐-­‐	  Post1CRT	   Starting	  from	  baseline	  dose	  
0910	   Cough	  response-­‐-­‐-­‐	  Post2CRT	   Starting	  from	  baseline	  dose	  
0920	   Cough	  response-­‐-­‐-­‐	  Post3CRT	   Starting	  from	  baseline	  dose	  
0930	   Cough	  response-­‐-­‐-­‐	  Post4CRT	   Starting	  from	  baseline	  dose	  
0932	   Reviewed	  	  by	  	  study	   physician.	  	  If	  	  medically	  	  stable	  	  IV	  line	  and	  monitors	  removed.	   	  
	   Directed	  to	  recovery	  area/	  lounge.	   	  
	   Monitored	  	  by	  	  study	  	  nurse.	  	  Leave	  	  once	  	  exit	  	  criteria	  met.	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Data and Statistical Analysis 
	  
	  
Statistical analyses were completed using Statistical Package for the Social Sciences 
Inc. (SPSS version 21, release 21.0.0). A p value <0.05 was considered statistically 
significant.  Descriptive statistics were initially performed to establish mean and standard 
deviation data for both effect site concentration (ESC) and cough reflex testing (CRT). 
Following this, we calculated the increments of change in CRT (M). Pearson’s correlation co- 
efficient (r) was conducted to determine the relationship between mean increments of CRT 
change (M) and mean effect site concentration (ng/ml). Lastly, a paired samples t-test was 
conducted to compare cough response thresholds between two conditions: baseline CRT and 
peak CRT. The analyses were based on increments of change with one increment equaling 
0.2M. 
	  
Effect site concentrations were established using AnesstAssist©. This is a computer 
generated modeling system which calculates estimates of drug effect site and plasma 
concentrations and probabilities of effects using mathematical models published in peer 
reviewed journals (Palma, 2009). There are 2 mathematical models used for calculating the 
pharmacokinetic and pharmacodynamics properties of intravenously administered Fentanyl 
in AnestAssist© (Palma, 2009). The first is that of Scott & Stanski (1987) which does not 
include co-variates such as age, gender, height. The second model derived by Shafer & 
Varvel (1991) accounts for co-variates and is the standard fentanyl pharmacokinetic model 
used by anaesthetists and clinical researchers. The model includes a triexponential equation: 
	   Cp(t)	   =	  Ae	  −	  αt	  +	  Be	  −	  βt	  +	  Ce	  −	  17t	  
	  
	  
In this equation Cp represents plasma concentration; t represents time; A, B, C are 
coefficients describing the relative contributions; α represents rapid-distribution half life; β 
represents slow-distribution half life and ϒ represents elimination half life. 
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Chapter 4: Results 
	  
	  
Both ESC and cough threshold are ratio and interval variables respectively. They both 
have an absolute zero point. They are quantitative numbers and are suitable for parametric 
tests.  Therefore, mean (rather than median) data are reported. 
	  
Effect site concentration (ESC) 
	  
	  
As shown in table 3, the ESC mean and standard deviations were calculated. The 
mean ESC between participants was similar at each assessment point. Standard deviations 
ranged between 0.01 and 0.27ng/ml.  This small range is attributed to the individualized 
fentanyl dosing-model employed. Each dose of fentanyl was calculated based on participant 
weight at 2mcg x kg (with a maximum total dose of 200mcg) rather than set doses of 50mcg 
per bolus. As discussed, AnestAssist© (Palma, 2009) was the modeling system used to 
calculate each participant’s fentanyl ESC. 
	  
Table 3 Mean ESC at each assessment point 
	  
ESC	  (ng/ml)	  
Mean	   SD	  
Baseline	   0.00 0.00	  
F1CRT	   0.65 0.02	  
F2CRT	   1.17 0.03	  
F3CRT	   1.57 0.03	  
F4CRT	   1.89 0.05	  
Post1CRT	   1.15 0.03	  
Post2CRT	   0.80 0.02	  
Post3CRT	   0.67 0.27	  
Post4CRT	   0.48 0.01	  
In the pre-administration period (baseline) ESC was zero. During the administration 
period (F1CRT-F4CRT) there was a constant increase in the mean ESC, with mean peak ESC 
at F4CRT, immediately post final dose of fentanyl.  In the post-administration period 
(Post1CRT-Post4CRT) there was a steady decrease in mean ESC values. Of note is the 
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finding that at Post4CRT (forty minutes post final administration of fentanyl) ESC ranged 
between 0.47-0.49ng/ml, it had not returned to zero. Using the pharmacokinetic model to 
predict how long it would take to return to an ESC of between 0.00-0.05ng/ml based on 
2mg/kg given at 5-minute intervals, all participants were estimated to take at least 1 hour and 
forty minutes. 
	  
Cough reflex testing (CRT) 
	  
	  
Table 4 Mean cough response at each assessment point 
	  
Cough	  Response	  (M)	  
	  
	   Mean	   SD	  
Baseline	   0.50	   0.28	  
F1CRT	   0.60	   0.43	  
F2CRT	   0.70	   0.43	  
F3CRT	   0.90	   0.43	  
F4CRT	   1.20	   0.50	  
Post1CRT	   1.00	   0.51	  
Post2CRT	   0.80	   0.51	  
Post3CRT	   0.70	   0.45	  
Post4CRT	   0.50	   0.29	  
	  
	  
	  
Each individual acted as their own control for suppressed cough reflex testing, the 
mean baseline response was 0.5M (min=0.4M, max= 1.4M, range=1.0M). Interestingly, 12 
participants had a suppressed baseline cough response at 0.4M. One participant (14M0589) 
did not change from his baseline dose. At all assessment points he had a present-strong 
response to 0.4M citric acid. He was removed from further cough response group analysis 
from this point onwards, therefore n= 13. Standard deviations at all assessment points were 
very tight, ranging between 0.0 and 0.54M. During the administration period (F1CRT- 
F4CRT) there was a constant increase in the mean CRT, with mean peak CRT at F4CRT, 
immediately post final dose of fentanyl.  In the post- administration period (Post1CRT- 
Post4CRT) there was a steady decrease in mean CRT values. 
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Increments of CRT change 
	  
The majority of participants (76.92 %) had their peak cough threshold in F4CRT 
(mean cough threshold of 1.20M compared to mean 0.5M baseline).  The effect site 
concentration of F4CRT was also the highest at this assessment point, at 1.89ng/ml. The 
second highest cough thresholds occurred in F3CRT (mean cough threshold 0.9M), with 
effect site concentrations at 1.57ng/ml. Therefore, at the highest ESC of fentanyl, cough 
sensitivity was the lowest. The largest mean number of increments of change in cough 
threshold occurred in F4CRT as shown in figure 5. 
	  
Mean	  increments	  of	  change	  
	   4	  
	   3.5	  
	   3	  
	   2.5	  
	   2	  
	   1.5	  
	   1	  
	   0.5	  
	   0	  
	  
	  
	  
	  
Phase	  
	  
Figure 4. Mean increments of cough reflex change. 
	  
	  
Pearson’s correlation co-efficient was conducted to determine the relationship 
between mean increments of CRT change (M) and mean effect site concentration (ng/ml). A 
positive correlation was found between the two variables at the 2-tailed level [r=9.19, n=9, 
p= <0.01]. 
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As detailed in the methods section, doses of citric acid ranged between 0.4M and 
1.6M, in increasing doses of 0.2M; giving a total of 7 doses of citric acid, with a range of 
1.2M citric acid. Of the 13 participants who had a change in their cough threshold from 
baseline, 5 increased by 6 or more units of citric acid (ceiling was reached at 1.6M), 1 had a 
change of 5 units of citric acid, 1 had a change of 4 units and the other 5 participants had a 
change of 3 or less units. In figure 5, red columns indicate ceiling was reached at our highest 
dose of 1.6M citric acid. 
	  
	  
	  
Max	  increments	  of	  CRT	  change	  
	   7	  6	  5	  4	  3	  2	  1	   Ceiling	  	  reached	  0	  
	  
	  
	  
	  
Participant	  
	  
Figure 5. Maximum increments of CRT change. 
	  
	  
A paired samples t-test was conducted to compare cough response thresholds between 
two conditions: baseline CRT and peak CRT [t= -5.701, df=13, p=<0.01]. There was a 
significant difference in the scores of baseline CRT (M=0.5, SD 0.28) and peak CRT 
(M=1.21, SD= 4.7). 
	  
The period in which participants returned to their own baseline was also calculated. 
Participants appear to either have returned to baseline rather rapidly (28 % returned to their 
own baseline in Post1CRT) or not until the final assessment (29% returned in Post4CRT). 
Fewer participants returned in the middle of the post assessment period (Post2CRT and 
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Post3CRT).  One participant (17F0390) required an extra assessment CRT, labeled as 
‘ExtraPsot5CRT,’ 50 minutes post final fentanyl administration to return to her own CRT 
baseline of 0.4M. Refer to figure 6. 
	  
Phase	  returned	  to	  baseline	  CRT	  
	   30.00%	  
	   25.00%	  
	   20.00%	  
	   15.00%	  
	   10.00%	  
	   5.00%	  
	   0.00%	  
	  
	  
	  
	  
	  
	  
Figure 6. Period returned to baseline CRT, by percentage. 
	  
	   .	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Chapter 5: Discussion 
	  
	  
Baseline cough thresholds 
	  
	  
The majority of participants had a baseline suppressed cough response at 0.4M. This 
threshold is lower than suppressed threshold levels reported in previous studies.  Because our 
participants were healthy volunteers, the most appropriate studies for comparison are 
normative studies employing the same method. Normative studies by necessity have 
extensive exclusion criteria, as did our study. In their investigation, Monroe (2010) reported 
70% of their healthy participants elicited a SCR at 0.8M. However, their dosing range was 
0.8M- 2.6M and they found a significant flooring effect, whereby participants may have had 
a present response to doses of citric acid lower than 0.8M had they been administered. Manco 
(2011) addressed this flooring effect by collecting normative data with a testing range 
between 0.1M and 1.2M. Despite testing at substantially lower does, they actually reported 
91.9% of participants had SCT at 0.9M- higher than the dose initially reported by Monroe 
(2010). Our data set was small and it is possible our median baseline dose of 0.5M may have 
increased with a larger sample size. 
	  
Fentanyl effect on CRT 
	  
	  
Our results support the findings of previous studies that show a clear reduction in 
cough strength sensitivity following intravenous administration of opiates (Tagaito, et al., 
1998; O'Connell, 2002; Fuller, et al., 1988). To our knowledge there are no identified studies 
that systematically investigate the cough reflex as the opioid effect site concentration is 
decreasing. This is perhaps where the clinically applicable information lies. We know that 
opioids decrease cough sensitivity, what needs further elucidation is to what extent and for 
what period of time. Clinically, this may help direct postoperative monitoring regimes in the 
future, including the assessment of which patients are safe to being eating and drinking across 
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the perioperative period. Current clinical protocols for resumption of oral intake 
postoperatively are site-specific and staff dependent. Pneumonia prevention programs have 
successfully been implemented in ICU settings, but no such protocols are in place for surgical 
wards (Wren, et al., 2010). Clinically, if a patient is deemed alert enough to eat then staff  
may commence them on an oral diet as early as in the recovery or post anaesthetic care unit. 
Unfortunately, those patients most at risk of developing postoperative aspiration pneumonia 
related to an impaired cough response may not show any overt signs of aspiration and will go 
undetected at bedside. The application of a screening test in the postoperative population may 
assist in identifying high-risk patients who require either a longer period of recovery time for 
resolution of cough suppression, or a referral to speech language therapy prior to resumption 
of oral intake. 
	  
Strengths and limitations 
	  
	  
The strengths of this study include: the fentanyl dosing model of 2mcg/kg and the use 
of a pharmacokinetic model to determine effect site concentrations in the brain.  Studies 
conducted on psychoactive drugs (e.g. fentanyl) cannot be completely blinded because the 
subject is conscious of the effects (Morice, et al., 2007). Participants must of course give 
informed consent to contribute to studies involving medicines, and as a result are necessarily 
informed of the potential effects. A blinded study where all participants consented to 
administration of fentanyl but a randomly assigned control group were administered a 
placebo could have improved this. Weaknesses of this study include: participants’ awareness 
during the administration period that fentanyl was being dispensed to them and in the post-
administration period that it was not. This may have impacted volitional cough suppression 
and could have been controlled for by blinding and/ or placebo administrations.   
	  
In an attempt to correct for some supramedullary impact on the assessment of cough 
reflex, suppressed cough response was used and presentations of citric acid were interspersed 
with saline. Participants were instructed to ‘try not to cough’. This may in fact represent a 
truer cough reflex than natural cough testing method. Research shows suppressed cough 
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reflex thresholds are higher than natural cough thresholds and although baseline 
	  
suppressed cough threshold was lower than previously reported studies; a ceiling was reached 
at 1.6M. 
	  
This was a pilot study investigating young, healthy participants with extensive 
exclusion criteria. The application of these data directly to the postoperative population is not 
possible because of these factors. The average surgical patient is likely to be older and have 
co-morbidities not accounted for in this study. For example, a recent study reported on 2,448 
patients undergoing hip surgery; mean age was 82 years with 35% having at least one 
comorbidity (Roche, Wenn, Sahota, & Moran, 2005).  However, cough reflex testing has 
been shown to correctly identify those patients who are at risk of silent aspiration 
(Addington, et al., 1999; Miles, Moore, et al., 2013). Cough testing is simple to administer 
and these results suggest further investigation into use in the postoperative setting is 
warranted. 
	  
Future directions 
	  
	  
In order to apply results generated from this research into clinical practice, normative 
data of suppressed cough thresholds would need to be generated in the preoperative and 
postoperative populations. It would then be reasonable to conduct a larger scale study 
comparing postoperative pneumonia rates in a sample of patients who received cough testing 
compared to a control group who received standard postoperative care. 
	  
Given the large role altered oropharyngeal flora plays in the development of 
aspiration pneumonia, another area of research that may benefit from investigation is the 
application of a strict oral hygiene protocol in preoperative and postoperative patients. 
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Conclusion 
	  
	  
This study is unique in identifying the effect of fentanyl on suppressed cough reflex 
post administration of a clinically relevant dose of 2 mcg/kg. The finding that cough reflex 
testing is sensitive enough to parallel changes in fentanyl effect site concentration in the brain 
is exciting and opens a potential area of clinical application in the postoperative population. 
	  
The degree of reflex suppression seen in this study has been associated with a 8-fold 
increase in aspiration risk in the dysphagic general medical population, where patients with 
an abnormal response to 0.8M of citric acid had an odds ratio for silent aspiration of 8.0 
(Miles, Moore, et al., 2013). Further research into the application of SCR in the post 
operative period may help identify those at particular risk of pulmonary complications and 
direct more intensive monitoring and alternative analgesic regimes. This would provide 
substantial health and cost benefits and improve patient outcomes. 
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Participant Information Sheet 
	  
	  
	  
Study title: The effect of Fentanyl on swallowing and cough response 
	  
	  
Locality: CDHB Ethics committee ref.: 12/NTB/39 
	  
	  
Lead investigator: Dr Geoffrey Shaw Contact phone number: 03 364 1077 
	  
	  
	  
	  
You are invited to take part in a study on the effect of fentanyl on swallowing and cough 
response. Whether or not you take part is your choice.  If you don’t want to take part, you 
don’t have to give a reason. If you do want to take part now, but change your mind later you 
can withdraw from the study at any time. 
	  
	  
This Participant Information Sheet will help you decide if you’d like to take part.  It explains 
why we are doing the study, what your participation would involve, what the benefits and 
risks to you might be, and what would happen after the study ends.  We will go through this 
information with you and answer any questions you may have. This will take about 15 
minutes.  You may also want to talk about the study with other people, such as family, 
whānau, friends, or healthcare providers.  Feel free to do this. 
	  
	  
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Participant Information Sheet 
and the Consent Form to keep. Participation in this study will be stopped should any harmful 
effects appear or if the doctor feels it is not in your best interests to continue. This document 
is 7 pages long including the Consent Form.  Please make sure you have all the pages. 
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Why are we doing the study? 
	  
When people undergo surgery, drugs are given to sedate them. Often they are also given 
drugs to help reduce pain. These drugs are called opioids. One such opioid is fentanyl. 
Fentanyl can affect breathing and cough. 
During and after surgery, people still swallow their saliva even if they are not eating and 
drinking. In healthy people there is a set pattern to breathing and swallowing. This is called 
swallowing respiratory coordination. It helps stop food, drink and saliva from going in to the 
lungs when we eat.  Breathing at the wrong time during swallowing can be a problem. When 
swallowed material goes ‘the wrong way’ it may go into the lungs, this is called aspiration. 
This can cause injury to the delicate air sacs in the lung. One way to protect our bodies from 
aspiration is to cough. Coughing forces material out of the lungs so that it can be re- 
swallowed. A reduced cough response reduces the ability to keep our lungs clean. 
We will look into the how fentanyl changes swallowing respiratory coordination and cough 
response. Both these functions are easily measured. Healthy participants will be asked to 
attend one session. An intravenous (in-vein, IV) cannula will be inserted. Each participant  
will receive four injections of fentanyl into the vein. Cough response to breathing in a mist of 
dilute citric acid (the sour part of lemon juice) and swallowing respiratory coordination will be 
measured after each injection. This will help us to understand what happens to people’s 
swallowing and cough function during and after surgery. 
We do not know how much fentanyl affects our ability to swallow and cough correctly. We 
also do not know if some people having surgery are much more sensitive to the effects of 
fentanyl, which might increase their chance of aspiration and lung injury. This study will help 
us learn more about this problem so that we can improve the safety and care of patients who 
need fentanyl for relief of their pain. This study has been approved by the Southern Health 
and Disability Ethics Committee and the University of Canterbury Committee. 
	  
	  
Who is conducting the study? Co-
ordinating  investigator: 
Dr Geoffrey Shaw, MBChB, FANZCA, FCICM , Intensive Care Specialist, Department of 
Intensive Care, Christchurch Hospital, Senior Clinical Lecturer, Department of Anaesthesia, 
University of Otago, Department of Intensive Care, Christchurch Hospital ,Christchurch, New 
Zealand.  Phone: (03) 364 1077. E-mail: geoff.shaw@cdhb.health.nz. 
Co-Investigators: 
	  
Maggie-Lee Huckabee, PhD , Senior Researcher, New Zealand Brain Research Institute , 
Senior Lecturer, Department of Communication Disorders, University of Canterbury, New 
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Zealand Brain Research Institute, 66 Stewart Street, Christchurch, New Zealand. Phone: 
	  
(3) 378 6070. E-Mail:   maggie-lee.huckabee@nzbri.org.nz 
	  
Helana Kelly, Master’s student, University of Canterbury, Ba App Sc (Speech Pathology), 
Speech Language Therapy Department, Christchurch Hospital, Private Bag 4710, 
Christchurch, New Zealand. Phone:(03) 364 1464.E-mail: helana.kelly@cdhb.health.nz.  
Faye Greenwood, RN, Registered Nurse (Expert), Post-Anaesthetic Care Unit,   
Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand. Phone: (03) 364 0640. 
Email:  faye.greenwood@cdhb.heath.nz. 
	  
	  
Who can participate? 
	  
Up to 20 healthy participants aged 18-70 will be asked to participate. 
	  
Exclusion  criteria: 
	  
• Allergy to opioids 
	  
• History of asthma 
	  
• History of chemical addiction 
	  
• History of neurological impairment (e.g. stroke, Myasthenia Gravis) 
	  
• Use of nicotine 3 months prior to study 
	  
• Alcohol consumption 8 hours prior to study 
	  
• Use of MAOI antidepressants 14 days prior to study 
	  
• Any medical or nursing professional/ student who may have current or future access 
to fentanyl. 
• Weight over 100 kg 
	  
	  
	  
What would your participation involve? 
	  
You are invited to attend 1 session. It will take 1.5-3 hours. The study will be completed at: 
	  
Gastroenterology Day Unit 
Level 1 Riverside 
Christchurch Public Hospital 
Riccarton Avenue, Christchurch 8041. 
	  
This site is fully equipped with emergency equipment. The coordinating investigator is an 
intensive care specialist. The co-researcher is a registered nurse. If you consent, the 
following will occur: 
	  
	  
Insertion of an Intravenous IV line 
	  
• A tourniquet (band) will be applied to your upper arm. 
	  
• The doctor will insert an intravenous IV cannula into your arm. 
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• This can be uncomfortable for a short period. 
	  
Administration of the drug Fentanyl 
	  
• The doctor will administer 4 doses of fentanyl. 
	  
• They will be 5 minutes apart. 
	  
• They will be given through your intravenous IV cannula. 
	  
	  
	  
Assessment of Cough Response (CR) 
	  
• You will place a plastic mask over your mouth and nose. 
	  
• A small chamber connected to the mask will be filled with different concentrations of 
citric acid. 
• This citric acid will be turned into a mist by a small device that forces air through it. 
	  
• You will breathe in and out for 15 seconds (maximum). 
	  
• This may cause you to want to cough. 
	  
• You will be asked to try and suppress (hold back) your cough. 
	  
• It can be mildly uncomfortable for a few seconds. 
	  
• You will have break of 30 seconds between each administration. 
	  
	  
	  
Removal of Intravenous IV line 
	  
• A registered nurse will remove the IV cannula. 
	  
• This may cause mild discomfort for a few seconds. 
	  
	  
	  
Monitoring 
	  
A registered nurse will monitor you during the study. Before you leave you will have: 
	  
• A final cough response (CR) test. 
	  
• Stable vital signs (including heart rate, blood pressure). 
	  
• A responsible adult to drive you home. 
	  
• A responsible adult at home. 
	  
	  
What are the possible benefits and risks to you of participating? 
	  
There are no known risks associated with assessing swallowing respiratory coordination 
(SRC) or cough response (CR) in healthy people. There are some possible side effects of 
fentanyl. 
These are listed below. 
	  
Common: Feeling “high”, mild nausea, slowed breathing and heart rate. 
	  
Less common: Low blood pressure, very slow breathing, blurred vision, small pupils, 
nausea, and dizziness 
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Rare: Jerky or stiff muscles, sweating, allergic reactions (resulting in 
wheezing, a rash and/or very low blood pressure), hypoventilation 
	  
	  
A doctor and nurse will monitor you closely. In the very unlikely event of any serious side 
effects, appropriate medications and equipment will be immediately available. 
	  
	  
Participation will not benefit you directly. You will be assisting in research to improve health 
outcomes. Participation will not cost you anything. You will receive no reimbursement. 
Fentanyl will not be available to you after the study. It is administered for research purposes 
only. 
What would happen if you were injured in the study? 
	  
If you were injured in this study, which is unlikely, you would be eligible for compensation 
from ACC just as you would be if you were injured in an accident at work or at home. 
If you have private health or life insurance, you may wish to check with your insurer that 
taking part in this study won’t affect your cover. 
What are the rights of participants in the study? 
	  
Whether or not you take part is your choice. If you don’t want to take part, you don’t have to 
give a reason. It won’t affect the care you receive now or in the future. If you do want to take 
part now, but change your mind later, you can withdraw from the study at any time. 
No material that could personally identify you will be used in any reports on this study. You 
are entitled to a copy of your data on request. 
What will happen after the study ends, or if you pull out? 
	  
You will be offered copies of the final publication of this project, or a summary in plain 
English. There will be no associated cost. However, the final publication will not be available 
for up to 18 months. 
Consent forms will be kept in a locked filing cabinet in the New Zealand Brain Research 
Institute. With your permission, de-identified (anonymous) research data will be stored on a 
computer so this material will be available for future researchers. These future studies that 
use this data may need to seek approval from a Health and Disability Ethics Committee. 
Where can you go for more information about the study, or to raise concerns or 
complaints? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact: 
Dr Geoffrey Shaw 
	  
Intensive Care Specialist 
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Phone: (03) 364 1077 
	  
E-mail:  geoff.shaw@cdhb.health.nz 
	  
If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
	  
	  
Phone: 0800 555 050 
	  
Fax: 0800 2 SUPPORT (0800 2787 7678) 
	  
Email: advocacy@hdc.org.nz 
	  
You can also contact the health and disability ethics committee (HDEC) that approved this 
study on: 
Phone: 0800 4 ETHICS 
	  
Email: hdecs@moh.govt.nz 
	  
You can also contact Christchurch Hospital Māori Health Services (Nga Ratonga Hauora 
Māori) on: 
Phone: (03) 364 0640 
	  
Fax: (03) 3786018 
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Appendix B: Participant Consent Form 
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Consent Form 
	  
	  
	  
Request for interpreter 
	  
	  
	  
English I wish to have an interpreter Yes No 
Deaf I wish to have a NZ sign language interpreter Yes No 
Māori E hiahia ana ahau ki tetahi kaiwhaka Māori/kaiwhaka pakeha korero Ae Kao 
Cook Island Māori Ka inangaro au i tetai tangata uri reo Ae Kare 
Fijian Au gadreva me dua e vakadewa vosa vei au Io Sega 
Niuean Fia manako au ke fakaaoga e taha tagata fakahokohoko kupu E Nakai 
Sāmoan Ou te mana’o ia i ai se fa’amatala upu Ioe Leai 
Tokelaun Ko au e fofou ki he tino ke fakaliliu te gagana Peletania ki na gagana o na 
motu o te Pahefika 
Ioe Leai 
Tongan Oku ou fiema’u ha fakatonulea Io Ikai 
Declaration by participant: 
	  
	  
I have read, or have had read to me in my first language, and I understand the Participant Information 
Sheet. I have had the opportunity to ask questions and I am satisfied with the answers I have 
received.I freely agree to participate in this study. I have been given a copy of the Participant 
Information Sheet and Consent Form to keep. 
	  
	  
Participant’s name: 
	  
	  
Signature: Date: 
	  
	  
Declaration by member of research team: 
	  
	  
I have given a verbal explanation of the research project to the participant, and have answered the 
participant’s questions about it. I believe that the participant understands the study and has given 
informed consent to participate. 
	  
	  
Researcher’s name: 
	  
	  
Signature: Date: 
THE	  EFFECT	  OF	  FENTANYL	  ON	  COUGH	  RESPONSE	   68	  	  
	  
	  
	  
	  
Appendix C: Summary Data Tables 
	  	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	   THE	  EFFECT	  OF	  FENTANYL	  ON	  COUGH	  RESPONSE  69	  
Summary table- Individual cough responses (CRT) 
	  
Participant	   Baseline	  
CRT	  (M)	  
F1CRT	  
(M)	  
	   F2CRT	  
(M)	  
	   F3CRT	  
(M)	  
	   F4CRT	  
(M)	  
	   Post1CRT	  
(M)	  
Post2CRT	  
(M)	  
Post3CRT	  
(M)	  
Post4CRT	  
(M)	  
2M0582	   0.4	   	   0.6	   	   1.0	   	   1.2	   	   1.4	   1.0	   0.8	   0.6	   0.4	  
3F0790	   0.4	   	   0.4	   	   0.8	   	   1.0	   	   1.0	   1.0	   0.4	   0.4	   0.4	  
4F0984	   0.4	   	   0.4	   	   0.4	   	   0.4	   	   0.6	   0.6	   0.4	   0.4	   0.4	  
5M0778	   0.4	   	   0.4	   	   0.8	   	   0.8	   	   1.6	   0.4	   0.4	   0.4	   0.4	  
6M0889	   0.4	   	   0.4	   	   0.4	   	   0.6	   	   0.4	   0.4	   0.4	   0.4	   0.4	  
9F0281	   0.8	   	   1.6	   	   1.6	   	   1.6	   	   1.6	   1.6	   1.6	   1.6	   0.8	  
10F0579	   0.4	   	   0.4	   	   0.4	   	   0.4	   	   0.6	   0.4	   0.4	   0.4	   0.4	  
11M1078	   0.4	   	   0.4	   	   0.6	   	   1.4	   	   1.6	   1.4	   0.4	   0.4	   0.4	  
12F0168	   1.4	   	   1.6	   	   1.6	   	   1.6	   	   1.6	   1.4	   1.4	   1.4	   1.4	  
14M0589	   0.4	   	   0.4	   	   0.4	   	   0.4	   	   0.4	   0.4	   0.4	   0.4	   0.4	  
15F1089	   0.4	   	   0.4	   	   0.4	   	   0.8	   	   1.2	   0.4	   0.4	   0.4	   0.4	  
16F1289	   0.4	   	   0.4	   	   0.4	   	   0.8	   	   1.6	   1.6	   1.4	   0.4	   0.4	  
17F0390	   0.4	   	   0.4	   	   0.4	   	   0.6	   	   1.6	   1.6	   1.6	   1.4	   0.8	  
18F0785	   0.4	   	   0.4	   	   0.8	   	   1.2	   	   1.6	   1.2	   1.0	   0.8	   0.4	  
MEAN	   0.5	   	   0.6	   	   0.7	   	   0.9	   	   1.2	   1.0	   0.8	   0.7	   0.5	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Summary table- effect site concentrations (ESC) 
	  
Participant	   ESC	  F1CRT	  
(ng/ml)	  
ESC	  F2CRT	  
(ng/ml)	  
ESC	  F3CRT	  
(ng/ml)	  
ESC	  F4CRT	  
(ng/ml)	  
Post1CRT	  
(ng/ml)	  
	   Post2CRT	  
(ng/ml)	  
	   Post3CRT	  
(ng/ml)	  
	   Post4CRT	  
(ng/ml)	  
	  
2M0582	   0.67	   1.2	   1.57	   1.94	   	   1.21	   	   0.83	   	   0.62	   	   0.49	  
3F0790	   0.66	   1.19	   1.56	   1.92	   	   1.14	   	   0.81	   	   0.60	   	   0.49	  
4F0984	   0.66	   1.18	   1.57	   1.91	   	   1.16	   	   0.83	   	   0.61	   	   0.49	  
5M0778	   0.65	   1.15	   1.54	   1.87	   	   1.11	   	   0.78	   	   0.60	   	   0.48	  
6M0889	   0.64	   1.14	   1.53	   1.85	   	   1.13	   	   0.77	   	   0.59	   	   0.47	  
9F0281	   0.63	   1.1	   1.52	   1.77	   	   1.11	   	   0.78	   	   0.58	   	   0.46	  
10F0579	   0.64	   1.16	   1.57	   1.89	   	   1.15	   	   0.81	   	   1.61	   	   0.48	  
11M1078	   0.66	   1.19	   1.59	   1.92	   	   1.15	   	   0.80	   	   0.60	   	   0.49	  
12F0168	   0.63	   1.14	   1.54	   1.81	   	   1.14	   	   0.79	   	   0.58	   	   0.47	  
14M0589	   0.67	   1.2	   1.61	   1.93	   	   1.20	   	   0.82	   	   0.63	   	   0.49	  
15F1089	   0.66	   1.19	   1.58	   1.92	   	   1.19	   	   0.81	   	   0.60	   	   0.49	  
16F1289	   0.68	   1.21	   1.62	   1.96	   	   1.19	   	   0.84	   	   0.62	   	   0.50	  
17F0390	   0.65	   1.14	   1.57	   1.89	   	   1.14	   	   0.79	   	   0.58	   	   0.48	  
18F0785	   0.64	   1.15	   1.55	   1.87	   	   1.12	   	   0.79	   	   0.59	   	   0.47	  
MEAN	   0.65	   1.17	   1.57	   1.89	   	   1.15	   	   0.80	   	   0.67	   	   0.48	  
SD	   0.02	   0.03	   0.03	   0.05	   	   0.03	   	   0.02	   	   0.27	   	   0.01	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Summary table- mean increments of cough (CRT) change 
	  
	  
	  
Participant	   Baseline	  
CRT	  (M)	  
F1CRT	  
Increments	  
change	  
F2CRT	  
Increments	  
change	  
F3CRT	  
Increments	  
change	  
F4CRT	  
Increments	  
change	  
Post1CRT	  
Increments	  
change	  
Post2CRT	  
Increments	  
change	  
Post3CRT	  
Increments	  
change	  
Post4CRT	  
Increments	  
change	  
2M0582	   0.4	   1	   3	   4	   5	   3	   2	   1	   0	  
3F0790	   0.4	   0	   2	   3	   3	   3	   0	   0	   0	  
4F0984	   0.4	   0	   0	   0	   1	   1	   0	   0	   0	  
5M0778	   0.4	   0	   2	   2	   6	   0	   0	   0	   0	  
6M0889	   0.4	   0	   0	   1	   0	   0	   0	   0	   0	  
9F0281	   0.8	   4	   4	   4	   4	   4	   4	   4	   0	  
10F0579	   0.4	   0	   0	   0	   1	   0	   0	   0	   0	  
11M1078	   0.4	   0	   1	   5	   6	   5	   0	   0	   0	  
12F0168	   1.4	   1	   1	   1	   1	   0	   0	   0	   0	  
14M0589	   0.4	   0	   0	   0	   0	   0	   0	   0	   0	  
15F1089	   0.4	   0	   0	   2	   4	   0	   0	   0	   0	  
16F1289	   0.4	   0	   0	   2	   5	   6	   5	   0	   0	  
17F0390	   0.4	   0	   0	   1	   6	   6	   6	   5	   2	  
18F0785	   0.4	   0	   2	   4	   6	   4	   3	   2	   0	  
Mean	  
Increments	  
Change	  
0.0	   0.4	   1.1	   2.1	   3.4	   2.3	   1.4	   0.9	   0.1	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Individual effect site concentration (ESC) generated by AnnestAssist™ 
	   Example	  based	  on	  participant	  2M0582	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Physiological data-Respiratory Rate (RR) 
	  
	  
	  
Participant	   BaseRR	   F1RR	   F2RR	   F3RR	   F4RR	   Post1RR	   Post2RR	   Post3RR	   Post4RR	  
2M0582	   13	   13	   11	   12	   12	   12	   12	   11	   12	  
3F0790	   15	   13	   M	   M	   M	   M	   M	   M	   M	  
4F0984	   15	   13	   M	   M	   M	   M	   M	   M	   M	  
5M0778	   12	   12	   14	   12	   12	   12	   10	   10	   10	  
6M0889	   14	   14	   12	   12	   10	   10	   10	   12	   12	  
9F0281	   16	   16	   16	   14	   14	   14	   12	   12	   12	  
10F0579	   16	   18	   20	   20	   18	   16	   16	   14	   M	  
11M1078	   16	   14	   12	   12	   14	   14	   16	   16	   14	  
12F0168	   16	   16	   16	   14	   14	   12	   9	   10	   8	  
14M0589	   16	   18	   16	   12	   10	   10	   10	   12	   14	  
15F1089	   16	   12	   12	   10	   10	   12	   16	   10	   8	  
16F1289	   16	   14	   14	   14	   14	   12	   10	   10	   12	  
17F0390	   12	   14	   14	   14	   10	   10	   8	   8	   10	  
18F0785	   14	   14	   12	   12	   12	   8	   10	   7	   6	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Physiological data- Arterial Oxygen Saturation (Sa02) 
	  
	  
	  
ID	   F1Sa02	   F2Sa02	   F3Sa02	   F4Sa02	   Post1Sa02	   Post2Sa02	   Post3Sa02	   Post4	  Sa02	  
2M0582	   97	   97	   97	   96	   94	   95	   96	   97	  
3F0790	   98	   97	   96	   95	   95	   96	   96	   M	  
4F0984	   100	   100	   96	   100	   100	   99	   M	   M	  
5M0778	   96	   96	   97	   97	   97	   94	   95	   96	  
6M0889	   100	   100	   97	   95	   96	   97	   99	   99	  
9F0281	   96	   96	   96	   96	   97	   97	   96	   96	  
10F0579	   100	   100	   100	   99	   99	   96	   98	   M	  
11M1078	   99	   98	   98	   97	   97	   97	   97	   98	  
12F0168	   100	   100	   100	   100	   100	   100	   100	   99	  
14M0589	   96	   96	   97	   94	   92	   94	   92	   95	  
15F1089	   98	   98	   98	   98	   98	   99	   98	   96	  
16F1289	   99	   99	   99	   96	   97	   96	   96	   96	  
17F0390	   97	   98	   100	   98	   99	   100	   100	   98	  
18F0785	   97	   98	   98	   97	   96	   97	   94	   96	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Physiological data- Blood Pressure (BP) 
	  
	  
	  
Base	   F1	   F2	   F3	   F4	   Post1	   Post2	   Post3	   Post4	  
	  
Participant	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	   SBP	   DBP	  
2M0582	   118	   78	   142	   82	   135	   95	   139	   90	   144	   92	   145	   95	   143	   85	   135	   85	   135	   85	  
3F0790	   110	   65	   98	   60	   105	   74	   115	   74	   121	   69	   117	   73	   114	   65	   110	   66	   M	   M	  
4F0984	   150	   80	   139	   74	   136	   75	   115	   85	   140	   85	   152	   74	   140	   66	   M	   M	   M	   M	  
5M0778	   122	   78	   115	   76	   118	   76	   135	   79	   127	   75	   132	   75	   140	   84	   139	   85	   134	   74	  
6M0889	   130	   80	   129	   94	   108	   75	   120	   75	   120	   75	   112	   75	   118	   85	   105	   68	   109	   74	  
9F0281	   124	   73	   138	   76	   135	   81	   139	   86	   144	   95	   135	   79	   109	   80	   135	   75	   139	   70	  
10F0579	   132	   86	   159	   86	   150	   90	   140	   86	   140	   76	   140	   85	   129	   78	   133	   80	   M	   M	  
11M1078	   105	   32	   85	   39	   84	   44	   85	   54	   85	   52	   86	   52	   90	   58	   100	   61	   105	   60	  
12F0168	   130	   90	   118	   83	   126	   78	   121	   80	   124	   84	   129	   94	   116	   83	   133	   79	   119	   83	  
14M0589	   129	   66	   110	   56	   120	   56	   120	   55	   115	   60	   120	   51	   120	   53	   125	   60	   110	   58	  
15F1089	   105	   60	   103	   60	   103	   64	   92	   60	   92	   60	   105	   45	   106	   45	   106	   56	   105	   58	  
16F1289	   120	   80	   123	   84	   125	   82	   125	   82	   110	   75	   120	   81	   119	   80	   120	   80	   115	   75	  
17F0390	   112	   75	   105	   82	   115	   70	   120	   70	   132	   77	   125	   80	   132	   70	   107	   70	   113	   78	  
18F0785	   105	   55	   110	   70	   126	   74	   120	   69	   119	   80	   119	   76	   130	   70	   122	   70	   124	   64	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Physiological data- Heart Rate (HR) 
	  
	  
	  
	  
ID	   BaseHR	   F1HR	   F2HR	   F3HR	   F4HR	   Post1HR	   Post2HR	   Post3HR	   Post4HR	  
2M0582	   77	   80	   90	   90	   85	   85	   85	   70	   70	  
3F0790	   85	   75	   85	   85	   85	   90	   70	   70	   M	  
4F0984	   115	   120	   105	   120	   125	   120	   105	   M	   M	  
5M0778	   65	   60	   75	   80	   85	   80	   65	   65	   70	  
6M0889	   65	   55	   75	   65	   70	   55	   65	   55	   55	  
9F0281	   90	   95	   95	   95	   95	   105	   90	   105	   105	  
10F0579	   100	   115	   125	   110	   100	   100	   85	   95	   M	  
11M1078	   60	   50	   65	   65	   75	   80	   80	   55	   50	  
12F0168	   110	   85	   105	   95	   95	   90	   85	   90	   82	  
14M0589	   75	   75	   85	   75	   70	   75	   75	   65	   65	  
15F1089	   80	   80	   75	   80	   80	   95	   100	   80	   75	  
16F1289	   115	   120	   130	   135	   110	   105	   105	   105	   105	  
17F0390	   105	   105	   105	   110	   105	   115	   105	   85	   95	  
18F0785	   70	   80	   85	   80	   95	   90	   80	   95	   95	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